| Loreto Sulit, MD | |
|
1955 W Frye Rd, Chandler, AZ 85224-6282 | |
| (480) 909-3870 | |
| Not Available |
| Full Name | Loreto Sulit |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 26 Years |
| Location | 1955 W Frye Rd, Chandler, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902890767 | NPI | - | NPPES |
| 60626 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 34253 (Arizona) | Secondary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | 34253 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Banner Baywood Medical Center | Mesa, AZ | Hospital |
| Banner Heart Hospital | Mesa, AZ | Hospital |
| Mountain Vista Medical Center, Lp | Mesa, AZ | Hospital |
| Chandler Regional Medical Center | Chandler, AZ | Hospital |
| Banner Desert Medical Center | Mesa, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pulmonary Consultants P C | 4183600539 | 10 |
| Sjhmc Physician Services | 4486646197 | 533 |
News Archive
Death rates among patients admitted to a Colorado trauma center appeared to decrease after the center's designation was upgraded, according to a report in the January issue of Archives of Surgery, one of the JAMA/Archives journals.
A protein specialist that opens the genomic door for DNA repair and gene expression also turns out to be a multi-tasking workhorse that protects the tips of chromosomes and dabbles in a protein-destruction complex, a team lead by researchers at The University of Texas M. D. Anderson Cancer Center reports in the Aug. 13 edition of Molecular Cell.
Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, announces today the extension of its knowledge database agreement with sanofi-aventis research & development for an additional three-year term.
Three University of Massachusetts Amherst scientists have received a four-year, $1.2 million EUREKA grant from the U.S. National Institutes of Health (NIH) to study folding and misfolding of secretory proteins in the cell's protein factory, the endoplasmic reticulum, where misfolding can lead to diseases such as cystic fibrosis and liver cirrhosis.
Seattle Genetics, Inc. announced today that it has submitted a Biologics License Application to the U.S. Food and Drug Administration for the use of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma and relapsed or refractory systemic anaplastic large cell lymphoma.
› Verified 1 days ago
| Entity Name | Sjhmc Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326098005 PECOS PAC ID: 4486646197 Enrollment ID: O20040401001189 |
News Archive
Death rates among patients admitted to a Colorado trauma center appeared to decrease after the center's designation was upgraded, according to a report in the January issue of Archives of Surgery, one of the JAMA/Archives journals.
A protein specialist that opens the genomic door for DNA repair and gene expression also turns out to be a multi-tasking workhorse that protects the tips of chromosomes and dabbles in a protein-destruction complex, a team lead by researchers at The University of Texas M. D. Anderson Cancer Center reports in the Aug. 13 edition of Molecular Cell.
Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, announces today the extension of its knowledge database agreement with sanofi-aventis research & development for an additional three-year term.
Three University of Massachusetts Amherst scientists have received a four-year, $1.2 million EUREKA grant from the U.S. National Institutes of Health (NIH) to study folding and misfolding of secretory proteins in the cell's protein factory, the endoplasmic reticulum, where misfolding can lead to diseases such as cystic fibrosis and liver cirrhosis.
Seattle Genetics, Inc. announced today that it has submitted a Biologics License Application to the U.S. Food and Drug Administration for the use of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma and relapsed or refractory systemic anaplastic large cell lymphoma.
› Verified 1 days ago
| Entity Name | Pulmonary Consultants P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497035091 PECOS PAC ID: 4183600539 Enrollment ID: O20040625001029 |
News Archive
Death rates among patients admitted to a Colorado trauma center appeared to decrease after the center's designation was upgraded, according to a report in the January issue of Archives of Surgery, one of the JAMA/Archives journals.
A protein specialist that opens the genomic door for DNA repair and gene expression also turns out to be a multi-tasking workhorse that protects the tips of chromosomes and dabbles in a protein-destruction complex, a team lead by researchers at The University of Texas M. D. Anderson Cancer Center reports in the Aug. 13 edition of Molecular Cell.
Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, announces today the extension of its knowledge database agreement with sanofi-aventis research & development for an additional three-year term.
Three University of Massachusetts Amherst scientists have received a four-year, $1.2 million EUREKA grant from the U.S. National Institutes of Health (NIH) to study folding and misfolding of secretory proteins in the cell's protein factory, the endoplasmic reticulum, where misfolding can lead to diseases such as cystic fibrosis and liver cirrhosis.
Seattle Genetics, Inc. announced today that it has submitted a Biologics License Application to the U.S. Food and Drug Administration for the use of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma and relapsed or refractory systemic anaplastic large cell lymphoma.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Loreto Sulit, MD Po Box 33269, Phoenix, AZ 85067-3269 Ph: (602) 406-4786 | Loreto Sulit, MD 1955 W Frye Rd, Chandler, AZ 85224-6282 Ph: (480) 909-3870 |
News Archive
Death rates among patients admitted to a Colorado trauma center appeared to decrease after the center's designation was upgraded, according to a report in the January issue of Archives of Surgery, one of the JAMA/Archives journals.
A protein specialist that opens the genomic door for DNA repair and gene expression also turns out to be a multi-tasking workhorse that protects the tips of chromosomes and dabbles in a protein-destruction complex, a team lead by researchers at The University of Texas M. D. Anderson Cancer Center reports in the Aug. 13 edition of Molecular Cell.
Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, announces today the extension of its knowledge database agreement with sanofi-aventis research & development for an additional three-year term.
Three University of Massachusetts Amherst scientists have received a four-year, $1.2 million EUREKA grant from the U.S. National Institutes of Health (NIH) to study folding and misfolding of secretory proteins in the cell's protein factory, the endoplasmic reticulum, where misfolding can lead to diseases such as cystic fibrosis and liver cirrhosis.
Seattle Genetics, Inc. announced today that it has submitted a Biologics License Application to the U.S. Food and Drug Administration for the use of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma and relapsed or refractory systemic anaplastic large cell lymphoma.
› Verified 1 days ago
Dr. Jaskanwal Singh Bisla, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1955 W Frye Rd, Chandler, AZ 85224 Phone: 480-428-5500 | |
Dr. Naga Nalini Tirumalasetty, MD,ECNU,FACE. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 908 W Chandler Blvd Ste 4, Chandler, AZ 85225 Phone: 480-269-6448 Fax: 779-204-2331 | |
Amer Al-khoudari, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 604 W Warner Rd Ste C1, Chandler, AZ 85225 Phone: 480-372-8200 Fax: 480-372-8222 | |
Bidya Lohani-sharma, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 845 E Warner Rd Ste 101, Chandler, AZ 85225 Phone: 480-786-5000 Fax: 480-786-5050 | |
Nisar Ahmed, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3115 S Price Rd, Chandler, AZ 85248 Phone: 480-926-0170 Fax: 480-452-0715 | |
Chuck Stephen Mangubat, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3115 S Price Rd, Chandler, AZ 85248 Phone: 480-926-0170 Fax: 480-452-0715 | |
Dr. Edward Markman, D.O. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 475 S Dobson Rd, Chandler, AZ 85224 Phone: 480-926-0170 |